Skip to content
★ Sign in to follow
ME

Marvin E. Rosenthale

Executive
Windtree Therapeutics Inc
Total declarations
30
Company
1
▲ Purchases (26 ops.)
€302k
▼ Sales (0 ops.)
—

Latest filing published 08 Aug 2016 for Windtree Therapeutics INC.

Insider track record

Disclosed buys
26
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
26
Positive at T+90
100%
Median T+90
+8.9%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Marvin E. Rosenthale: trading record in brief

All filings by Marvin E. Rosenthale on record concern Windtree Therapeutics Inc. Over a trading history stretching from 1 March 2007 to 4 August 2016, the count stands at 30 filings.

On the market, this insider has only ever bought: 26 purchases, €302k in total. The totals do not cover 4 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 share grants.

In size, the median ticket on the buying side is €11k. Ninety days after publication, 5 purchases show a median change of +8.9%, with the price up in 100% of them. These figures describe past trades and do not predict future prices.

On 8 August 2016 came the latest disclosure, a share grant in Windtree Therapeutics Inc. The clock since the last published purchase (20 November 2008) now reads 6,563 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Marvin E. Rosenthale

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations28 total

25 of 28 declarations